Reni, M., Balzano, G., Zanon, S., Passoni, P., Nicoletti, R., Arcidiacono, P. G., . . . Gianni, L. (2016). Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma. Br J Cancer.
Chicago ZitierstilReni, Michele, et al. "Phase 1B Trial of Nab-paclitaxel Plus Gemcitabine, Capecitabine, and Cisplatin (PAXG Regimen) in Patients With Unresectable or Borderline Resectable Pancreatic Adenocarcinoma." Br J Cancer 2016.
MLA ZitierstilReni, Michele, et al. "Phase 1B Trial of Nab-paclitaxel Plus Gemcitabine, Capecitabine, and Cisplatin (PAXG Regimen) in Patients With Unresectable or Borderline Resectable Pancreatic Adenocarcinoma." Br J Cancer 2016.